- Category
- Micro (2024-25)
- Udyam number
- UDYAM-MH-26-0471500

About Rajaswa Pharmaceuticals Private Limited
Data last updated:
Rajaswa Pharmaceuticals Private Limited is a private limited company based in Pune, Maharashtra, India. It operates in the consumer and professional services segment of the travel and hospitality sector. It was incorporated on 10 April 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Pune, under CIN U93090PN2018PTC175909. Its GSTIN is 27AAICR8772M1ZH (Maharashtra).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Rohini Vaibhav Dhamdhere and Vaibhav Prakash Dhamdhere.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at S No 12/1/A Wadgaon Sheri Trimbakeshwar Co Op Housing Society, Pune, Maharashtra, India – 411014.
As per the financials filed for FY 2024, the company reported a revenue of ₹1.45 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹2.13 Lakh (net margin 1.5%) and EBITDA of ₹17.16 Lakh (EBITDA margin 11.8%).
As per MCA filings, the company has open charges of ₹49.82 Lakh on record.
Rajaswa Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-26-0471500). For more details, the company can be reached via its website rajaswa.in.
Company details
Recognitions & Rankings of Rajaswa Pharmaceuticals
Contact details
Rajaswa Pharmaceuticals Private Limited's registered office is in Pune, Maharashtra. Its website is rajaswa.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressS No 12/1/A Wadgaon Sheri Trimbakeshwar Co Op Housing Society, Pune, Maharashtra, India – 411014
- IndustryTravel and Hospitality, Consumer Professional Services
To see the full contact details of Rajaswa Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Rajaswa Pharmaceuticals is professional, scientific and technical activities. In detail, this covers scientific research and development.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| M | Professional, scientific and technical activities | 72 | Scientific research and development |
To see the full business activity and turnover split of Rajaswa Pharmaceuticals Private Limited, buy the company report.
Financials of Rajaswa Pharmaceuticals Private Limited
FY 2025 filings availableRajaswa Pharmaceuticals Private Limited reported revenue of ₹1.45 Cr (up 253% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue rose 253% in the latest year. EBITDA rose 897% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹17.16 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹2.13 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 11.8% | ||||
| Net Profit Margin | 1.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Rajaswa Pharmaceuticals Private Limited, buy the company report.
Board of directors of Rajaswa Pharmaceuticals Private Limited
Rajaswa Pharmaceuticals has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rohini Vaibhav Dhamdhere Also directs: Vibhraj Lifescience Private Limited | Director | 10 Apr 2018 | 8 Years 7 Months | Current |
| Vaibhav Prakash Dhamdhere Also directs: Vibhraj Lifescience Private Limited | Director | 12 Sep 2023 | 3 Years 2 Months | Current |
Auditor
Rajaswa Pharmaceuticals Private Limited is audited by D M SHINDE & CO. for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| D M SHINDE & CO. | FY 2023 | 134221W |
Shareholding
The shareholding of Rajaswa Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Rajaswa Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 09 Mar 2022 | 100560734 | Others | ₹49.82 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Rajaswa Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Rajaswa Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Rajaswa Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAICR8772M1ZH | Maharashtra | Active | 13 Aug 2021 |
To see the full GST registrations and return filing status of Rajaswa Pharmaceuticals Private Limited, buy the company report.
Recent activity
Rajaswa Pharmaceuticals Private Limited has 4 board changes on record since 2018: 2 appointments and 2 cessations. The latest: Seema Prasad Kadam ceased to be Director on 12 Sep 2023.
Frequently asked questions
Rajaswa Pharmaceuticals is an active private limited company based in Pune, Maharashtra, India. The company works in consumer professional services, within the travel and hospitality industry. It was incorporated on 10 April 2018 (8+ years old) and is registered under CIN U93090PN2018PTC175909.
Rajaswa Pharmaceuticals has 2 current directors:
- Rohini Vaibhav Dhamdhere - Director
- Vaibhav Prakash Dhamdhere - Director
The latest financial statements of Rajaswa Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Rajaswa Pharmaceuticals is 27AAICR8772M1ZH, registered in Maharashtra.
The CIN (Corporate Identification Number) of Rajaswa Pharmaceuticals is U93090PN2018PTC175909. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Rajaswa Pharmaceuticals was incorporated on 10 April 2018, making it 8+ years old. It is registered with the Registrar of Companies, Pune.
Seema Prasad Kadam ceased to be Director on 12 Sep 2023. Vaibhav Prakash Dhamdhere was appointed as Director on 12 Sep 2023. Vaibhav Prakash Dhamdhere ceased to be Director on 08 Mar 2021. Rajaswa Pharmaceuticals has 4 board changes on record in total.
Yes, Rajaswa Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-MH-26-0471500).
Rajaswa Pharmaceuticals can be reached through the website rajaswa.in. Its registered office is in Pune, Maharashtra, India.
The registered office of Rajaswa Pharmaceuticals is at S No 121A Wadgaon Sheri Trimbakeshwar Co Op Housing Society, Pune, Maharashtra, India – 411014.

